For investors, by investors
Results 71 - 80 of 1709 : Previous 4 5 6 7 8 9 10 11 12 Next
Here's How Johnson & Johnson May Be Failing You
Keep your eye on margins.
Human Genome Shares Soared: What You Need to Know
Is this meaningful? Or just another movement?
This Just In: Upgrades and Downgrades
Ladenburg lays a bet on Novavax.
Here's 1 Reason Gilead Sciences Looks Weak
Keep your eye on margins.
A settlement with Bayer turns Onyx into an instant buyout candidate.
Analysts are unanimously bullish, but do you agree with these Wall Street darlings?
AngioDynamics is cheaper than it looks.
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage
An unprecedented cancer drug development deal.
Pfizer's Selling, Not Buying, Pipeline Drugs?
Perhaps it's for the best.
Where no biotech news falls through the cracks.
Results 71 - 80 of 1709 : Previous 4 5 6 7 8 9 10 11 12 Next
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK